Merck & Co Inc Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/2/2026)
| Balance Sheet | Total Assets | 136,866,000,000.00 | ROE | 37.93 % |
| Balance Sheet | Total Equity | 51,907,000,000.00 | ROA | 13.34 % |
| Cashflow | Capital Expenditures | -4,112,000,000.00 | P/FCF | 29.89 |
| Cashflow | Free Cash Flow | 12,359,999,488.00 | – | – |
| Cashflow | Operating Cash Flow | 16,472,000,000.00 | P/CF | 22.43 |
| Income | Earnings per Share (diluted) | 7.28 | Div. Yield | 2.23 % |
| Income | Net Income | 18,254,000,000.00 | P/E | 20.24 |
| Income | Shares Outstanding | 2,507,000,000.00 | P/B | 7.12 |
| Income | Total Revenue | 65,011,000,000.00 | P/S | 5.68 |
Ratios calculated on: 10/14/2026
Company Description
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Effective February 25, 2013, Dashtag, a unit of Merck & Co Inc's Schering Plough Corp subsidiary acquired 17.95% interest in Fulford (India) Ltd.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.merck.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more